Literature DB >> 8670128

Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.

R P Fabunmi1, A H Baker, E J Murray, R F Booth, A C Newby.   

Abstract

The migration and proliferation of vascular smooth muscle cells (SMCs) during neointima formation in atherosclerosis and angioplasty restenosis is mediated by certain growth factors and cytokines, one action of which may be to promote basement-membrane degradation. To test this hypothesis further, the effects of such growth factors and cytokines on the synthesis of two basement-membrane-degrading metalloproteinases, namely the 72 kDa gelatinase (MMP-2, gelatinase A) and the 95 kDa gelatinase (MMP-9, gelatinase B) and three tissue inhibitors of metalloproteinases (TIMPs) was studied in primary cultured rabbit aortic SMCs. Expression of the 95 kDa gelatinase was increased by phorbol myristate acetate, foetal calf serum, thrombin and interleukin-1alpha (IL-1alpha); platelet-derived growth factor (PDGF) BB alone had no effect but acted synergistically with IL-1alpha. A selective protein kinase C inhibitor, Ro 31-8220, abolished induction of the 95 kDa gelatinase. In contrast, none of the agents tested modulated the synthesis of the 72 kDa gelatinase. We conclude that maximal up-regulation of 95 kDa gelatinase expression requires the concerted action of growth factors and inflammatory cytokines mediated, in part, by a protein kinase C-dependent pathway. TIMP-1 and TIMP-2 were highly expressed, and their synthesis was not affected by growth factors or cytokines. Expression of TIMP-3 mRNAs was, however, increased by PDGF and transforming growth factor beta, especially in combination. Divergent regulation of gelatinase and TIMP expression implies that either net synthesis or net degradation of basement membrane can be mediated by appropriate combinations of growth factors and cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8670128      PMCID: PMC1217192          DOI: 10.1042/bj3150335

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  55 in total

Review 1.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

2.  Effect of linoleic acid hydroperoxide on production of matrix metalloproteinases by human aortic endothelial and smooth muscle cells.

Authors:  Y Sasaguri; N Kakita; N Murahashi; S Kato; K Hiraoka; M Morimatsu; K Yagi
Journal:  Atherosclerosis       Date:  1993-05       Impact factor: 5.162

3.  Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation.

Authors:  R R Pauly; A Passaniti; C Bilato; R Monticone; L Cheng; N Papadopoulos; Y A Gluzband; L Smith; C Weinstein; E G Lakatta
Journal:  Circ Res       Date:  1994-07       Impact factor: 17.367

4.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

5.  Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family.

Authors:  J A Uría; A A Ferrando; G Velasco; J M Freije; C López-Otín
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

6.  v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.

Authors:  H Sato; M Kita; M Seiki
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

Review 7.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

8.  Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

Authors:  Z S Galis; M Muszynski; G K Sukhova; E Simon-Morrissey; E N Unemori; M W Lark; E Amento; P Libby
Journal:  Circ Res       Date:  1994-07       Impact factor: 17.367

9.  Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of the atherosclerotic process.

Authors:  T K Walters; D A Gorog; R F Wood
Journal:  J Vasc Res       Date:  1994 May-Jun       Impact factor: 1.934

10.  Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes.

Authors:  S M Wahl; J B Allen; B S Weeks; H L Wong; P E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

View more
  29 in total

1.  Assessment of the involvement of the macrophage migration inhibitory factor-glucocorticoid regulatory dyad in the expression of matrix metalloproteinase-2 during periodontitis.

Authors:  Josefine Hirschfeld; Mohammed Howait; Alexandru Movila; Marijo Parčina; Isabelle Bekeredjian-Ding; James Deschner; Søren Jepsen; Toshihisa Kawai
Journal:  Eur J Oral Sci       Date:  2017-08-04       Impact factor: 2.612

2.  Increased matrix metalloproteinase-9 activity in human ovarian cancer cells cultured with conditioned medium from human peritoneal tissue.

Authors:  K Shibata; F Kikkawa; A Nawa; K Tamakoshi; N Suganuma; Y Tomoda
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

3.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

Authors:  A H Baker; A B Zaltsman; S J George; A C Newby
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

4.  Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease.

Authors:  Pong Kian Chua; Marian E Melish; Qigui Yu; Richard Yanagihara; Kara S Yamamoto; Vivek R Nerurkar
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration.

Authors:  Jianhua S Yao; Fanxia Shen; William L Young; Guo-Yuan Yang
Journal:  Neurochem Int       Date:  2006-12-04       Impact factor: 3.921

Review 6.  Vascular smooth muscle cells in cerebral aneurysm pathogenesis.

Authors:  Robert M Starke; Nohra Chalouhi; Dale Ding; Daniel M S Raper; M Sean Mckisic; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-10-10       Impact factor: 6.829

7.  Cortical spreading depression activates and upregulates MMP-9.

Authors:  Yasemin Gursoy-Ozdemir; Jianhua Qiu; Norihiro Matsuoka; Hayrunnisa Bolay; Daniela Bermpohl; Hongwei Jin; Xiaoying Wang; Gary A Rosenberg; Eng H Lo; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells.

Authors:  N Marx; U Schönbeck; M A Lazar; P Libby; J Plutzky
Journal:  Circ Res       Date:  1998-11-30       Impact factor: 17.367

Review 9.  Metalloproteinases and vulnerable atherosclerotic plaques.

Authors:  Andrew C Newby
Journal:  Trends Cardiovasc Med       Date:  2007-11       Impact factor: 6.677

10.  Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production.

Authors:  Hitesh S Deshmukh; Colleen Shaver; Lisa M Case; Maggie Dietsch; Scott C Wesselkamper; William D Hardie; Thomas R Korfhagen; Massimo Corradi; Jay A Nadel; Michael T Borchers; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2007-11-15       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.